| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/22/1998 | CN1179829A Inhibition of tau-tau association |
| 04/22/1998 | CN1179774A Arginine analogues having nitric oxide synthase inhibitor activity |
| 04/22/1998 | CN1179321A Epilepsy recovering pill and preparing process thereof |
| 04/22/1998 | CN1038131C Pyrrolopyrimidines and its preparing intermediate and medicinal composition containing same and use |
| 04/21/1998 | US5741910 Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools |
| 04/21/1998 | US5741907 Pharmacologically active enantiomers |
| 04/21/1998 | US5741819 Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors |
| 04/21/1998 | US5741818 Semicarbazones having CNS activity and pharmaceutical preparations containing same |
| 04/21/1998 | US5741815 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 04/21/1998 | US5741808 Protein kinase inhibitors for treatmen of neurological disorders |
| 04/21/1998 | US5741806 Suppository compositions containing ondasetron dihydrate |
| 04/21/1998 | US5741802 Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system |
| 04/21/1998 | US5741797 Heteroatom substituted alkyl benzylaminoquinuclidines |
| 04/21/1998 | US5741790 Tachykinin antagonist and intermediates for nervous system disorders, antiinflammatory agents, antiarthritic agents, antidepressants and gastrointestinal disorders |
| 04/21/1998 | US5741788 Heterocyclic compounds and their preparation and use |
| 04/21/1998 | US5741787 Psychological disorders |
| 04/21/1998 | US5741785 Imidazolo(1,2-a)quinoxalinone compounds; antiischemic agents; nervous system disorders |
| 04/21/1998 | US5741778 Preventing neuronal cell death |
| 04/21/1998 | US5741776 Method of administration of IGF-I |
| 04/21/1998 | CA2087004C Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases |
| 04/18/1998 | CA2218782A1 Pharmaceutical compounds |
| 04/16/1998 | WO1998015615A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | WO1998015553A1 5-HETEROATOM-CONTAINING ALKYL SUBSTITUTED-3-OXO-PYRIDO(1,2-a) BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 04/16/1998 | WO1998015552A1 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS |
| 04/16/1998 | WO1998015550A1 N-substituted azaheterocyclic compounds |
| 04/16/1998 | WO1998015549A1 N-substituted azaheterocyclic compounds |
| 04/16/1998 | WO1998015548A1 1,4-disubstituted piperazines |
| 04/16/1998 | WO1998015546A1 N-substituted azaheterocyclic compounds |
| 04/16/1998 | WO1998015545A1 New serotonin 5-ht1f agonists |
| 04/16/1998 | WO1998015543A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 04/16/1998 | WO1998015542A1 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
| 04/16/1998 | WO1998015535A1 1,4-benzodiazepinones and their uses as cck antagonists |
| 04/16/1998 | WO1998015526A1 O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same |
| 04/16/1998 | WO1998015277A2 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agents |
| 04/16/1998 | WO1998015275A2 Method and potentiated composition for treating migraine |
| 04/16/1998 | WO1998015274A1 Novel compounds useful as neuro-protective agents |
| 04/16/1998 | WO1998015270A1 Anticonvulsant derivatives useful in treating neuropathic pain |
| 04/16/1998 | WO1998015268A1 Pharmaceutical microspheres of valproic acid for oral administration |
| 04/16/1998 | WO1998015267A1 Method for the treatment of neurological or neuropsychiatric disorders |
| 04/16/1998 | DE19642591A1 Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung New piperidine-ketocarboxylic acid derivatives, their preparation and application |
| 04/16/1998 | DE19642255A1 Verwendung von 1-Benzyl-3-(substituierten-hetaryl) -kondensierten Pyrazol-Derivaten Use of 1-benzyl-3- (substituted-heteroaryl) -kondensierten pyrazole derivatives |
| 04/16/1998 | CA2270661A1 Novel compounds useful as neuro-protective agents |
| 04/16/1998 | CA2268284A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | CA2268164A1 New serotonin 5-ht1f agonists |
| 04/16/1998 | CA2267943A1 5-heteroatom-containing alkyl substituted-3-oxo-pyrido(1,2-a) benzimidazole-4-carboxamide derivatives useful in treating central nervous system disorders |
| 04/16/1998 | CA2267835A1 1,4-disubstituted piperazines |
| 04/16/1998 | CA2267691A1 N-substituted azaheterocyclic compounds |
| 04/16/1998 | CA2267500A1 N-substituted azaheterocyclic compounds |
| 04/16/1998 | CA2267381A1 Method for the treatment of neurological or neuropsychiatric disorders |
| 04/16/1998 | CA2267154A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 04/16/1998 | CA2266773A1 Use of a nk-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| 04/16/1998 | CA2266376A1 1h-pyrido¬3,4-b|indole-4-carboxamide derivatives, preparation and application thereof in therapeutics |
| 04/15/1998 | EP0835936A2 Arginyl tRNA synthase |
| 04/15/1998 | EP0835869A2 New serotonin 5-HT1F agonists |
| 04/15/1998 | EP0835868A1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods |
| 04/15/1998 | EP0835659A1 Use of non-peptidic bradykinin antagonists in the preparation of medicaments for the treatment and prevention of Alzheimer's disease |
| 04/15/1998 | EP0835656A1 Combination drug containing tramadol and a calcium channel antagonist |
| 04/15/1998 | EP0835306A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 04/15/1998 | EP0835264A1 Human g-protein receptor hcegh45 |
| 04/15/1998 | EP0835255A1 Novel substituted azacyclic compounds |
| 04/15/1998 | EP0835254A1 Oxazolidinone derivatives, their preparation and therapeutical use |
| 04/15/1998 | EP0835253A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 04/15/1998 | EP0835246A1 Aromatic compounds and pharmaceutical compositions containing them |
| 04/15/1998 | EP0835128A1 Use of il-11 to treat inflammation |
| 04/15/1998 | EP0835127A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
| 04/15/1998 | EP0835126A1 Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
| 04/15/1998 | EP0835125A1 Cd4-derived peptides that inhibit immune responses |
| 04/15/1998 | EP0714388B1 Vasoconstrictive substituted aryloxyalkyl diamines |
| 04/15/1998 | CN1179160A Process and crystal form of 2-methyl -thieno -benzodiazepine |
| 04/15/1998 | CN1179156A Indole derivatives as 5 -HT receptor antagonist |
| 04/15/1998 | CN1179106A Recombinant human alpha-fetoprotein and uses thereof |
| 04/15/1998 | CN1179103A Prilocaine and hydrofluorocarbon aerosol preparations |
| 04/15/1998 | CN1179102A Oral 2 -methyl -thieno -benzodiazepine formulation |
| 04/15/1998 | CN1178698A Naoxinkang preparation and its producing technology |
| 04/15/1998 | CN1178685A Cool health-care medicine |
| 04/15/1998 | CN1038032C £(Benzodioxan, benzofuran or benzopyran) alkylamino| alkyl substituted guanidines and its preparing method, use and intermediate |
| 04/14/1998 | US5739387 Process for producing threo-3-(3,4-dihydroxyphenyl)serine |
| 04/14/1998 | US5739351 Neurokinin a antagonists |
| 04/14/1998 | US5739338 Skin disorders, antiinflammatory agents, antitumor agents, vision defects, viricides, immunosuppressants |
| 04/14/1998 | US5739322 Process for preparing BIS-indolyl macrocycles |
| 04/14/1998 | US5739307 Cell growth factors |
| 04/14/1998 | US5739167 Desferrioxamine-B salts and their use as orally effective iron chelators |
| 04/14/1998 | US5739166 Alkylsulfonyl or aminosulfonyl substituted aromatic compounds as non-steroidal antiinflammatory agent |
| 04/14/1998 | US5739165 Reducing sugar-free mixture of ibuprofen and phenylpropanolamine; heat and storage stability, discoloration inhibition |
| 04/14/1998 | US5739164 Block metabotropic glutamate receptors |
| 04/14/1998 | US5739158 Nitrogen-containing cyclohetero cycloalkylaminoaryl derivatives for CNS disorders |
| 04/14/1998 | US5739151 Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride |
| 04/14/1998 | US5739148 6-(2-Imidazolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists |
| 04/14/1998 | US5739138 Modulators of cellular response |
| 04/14/1998 | US5739133 Pyridazinedione compounds useful in treating neurological disorders |
| 04/14/1998 | US5739117 Treatment of brain disorders resulting from reduced capacity of active glucose transport through blood-brain barrier |
| 04/14/1998 | US5738873 Pharmaceutical formulations and methods for treating patients suffering from diseases that cause muscular hypotonia |
| 04/14/1998 | CA2010035C Proline derivatives |
| 04/10/1998 | CA2217810A1 2-aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods |
| 04/09/1998 | WO1998014598A1 INTERLEUKIN-1β CONVERTING ENZYME LIKE CYSTEINE PROTEASE |
| 04/09/1998 | WO1998014596A2 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | WO1998014572A1 Novel human phospholemman-like protein |
| 04/09/1998 | WO1998014473A1 Colostrinin, and uses thereof |
| 04/09/1998 | WO1998014447A1 Novel indole-2,3-dione-3-oxime derivatives |
| 04/09/1998 | WO1998014444A1 N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics |